News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect ...
1don MSN
FDA Commissioner Marty Makary defended the U.S. federal health agencies recent removal of the COVID-19 vaccine from the ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...
Despite Health Secretary Robert F Kennedy Jr’s announcement ending covid-19 vaccine recommendations for healthy children and pregnant women, the Centers for Disease Control and Prevention (CDC) has ...
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
While RFK Jr. said the coronavirus vaccine would be removed from the CDC schedule for healthy children, it’s still ...
A new Covid variant that’s gaining momentum globally has landed in the U.S. The World Health Organization announced last week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback